pH-Programmed Poly(amino acid) Nanoparticles for Mucus-Penetrating and Bacteria-Targeted Eradication of Helicobacter pylori
ACS Nano · 2026
DOI: 10.1021/acsnano.6c00335 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Yizhen You und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing1…. Hauptthemen laut MEDLINE: Helicobacter pylori, Nanoparticles, Anti-Bacterial Agents, Amoxicillin. Die Arbeit nennt 50 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, Beijing University of Chemical Technology, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
The global prevalence of Helicobacter pylori (H. pylori) infection stands in stark contrast to the limited clinical efficacy of antibiotics, primarily attributed to their rapid inactivation under gastric acidity and poor penetration through the gastric mucus barrier. Here, we report a pH-programmed poly(amino acid)-based nanoplatform for the precise eradication of H. pylori. This platform is constructed from poly(amino acid) block copolymers (FAR) incorporating d-aminoalanine side chains and rhamnolipid (RHL) moieties, which self-assemble into amoxicillin-loaded nanoparticles (Am@FAR NPs). Under strongly acidic gastric conditions (pH < 3), Am@FAR NPs undergo extensive protonation, adopting a compact, stabilized configuration that suppresses premature drug release and preserves antibiotic activity. Upon entering the gastric mucus layer (pH ∼ 4–6), partial deprotonation induces surface charge reversal, reducing nonspecific mucin adhesion and facilitating efficient mucus penetration. Cooperative recognition, mediated by RHL and d-aminoalanine residues, enables selective targeting of H. pylori within the mucus niche; here, further local pH elevation (∼6–7) triggers particle swelling and on-site drug release. Consequently, Am@FAR NPs achieve 99.99% eradication efficiency against H. pyloriin vivo, offering a highly effective and biocompatible strategy for the treatment of gastric H. pylori infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, Beijing University of Chemical Technology, Beijing100029, People's Republic of China.
- Department of Gastroenterology, China-Japan Friendship Hospital, Beijing100029, People's Republic of China.
ORCID-Profile: Guofeng Li, Xing Wang
Förderung
- Natural Science Foundation of Beijing Municipality
- Beijing University of Chemical Technology
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
You, Y., Zhou, Y., Han, R., Zhao, D., Yin, Z., Niu, J., Ni, Q., Li, L., Xie, W., Du, S., Liu, F., Li, G., & Wang, X. (2026). pH-Programmed Poly(amino acid) Nanoparticles for Mucus-Penetrating and Bacteria-Targeted Eradication of Helicobacter pylori. ACS Nano. https://doi.org/10.1021/acsnano.6c00335
Vancouver
You Y, Zhou Y, Han R, Zhao D, Yin Z, Niu J, et al. pH-Programmed Poly(amino acid) Nanoparticles for Mucus-Penetrating and Bacteria-Targeted Eradication of Helicobacter pylori. ACS Nano. 2026. doi:10.1021/acsnano.6c00335
BibTeX
@article{You2026,
author = {You, Yizhen and Zhou, Yuhang and Han, Runyu and Zhao, Dongdong and Yin, Zibo and Niu, Jiazhen and Ni, Qing and Li, Liwen and Xie, Wensheng and Du, Shiyu and Liu, Fang and Li, Guofeng and Wang, Xing},
title = {pH-Programmed Poly(amino acid) Nanoparticles for Mucus-Penetrating and Bacteria-Targeted Eradication of Helicobacter pylori},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c00335}
}
EUVIMED